These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

818 related articles for article (PubMed ID: 22315951)

  • 1. Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome.
    Chassard C; Dapoigny M; Scott KP; Crouzet L; Del'homme C; Marquet P; Martin JC; Pickering G; Ardid D; Eschalier A; Dubray C; Flint HJ; Bernalier-Donadille A
    Aliment Pharmacol Ther; 2012 Apr; 35(7):828-38. PubMed ID: 22315951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome.
    Rajilić-Stojanović M; Biagi E; Heilig HG; Kajander K; Kekkonen RA; Tims S; de Vos WM
    Gastroenterology; 2011 Nov; 141(5):1792-801. PubMed ID: 21820992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct microbial populations exist in the mucosa-associated microbiota of sub-groups of irritable bowel syndrome.
    Parkes GC; Rayment NB; Hudspith BN; Petrovska L; Lomer MC; Brostoff J; Whelan K; Sanderson JD
    Neurogastroenterol Motil; 2012 Jan; 24(1):31-9. PubMed ID: 22070725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR.
    Malinen E; Rinttilä T; Kajander K; Mättö J; Kassinen A; Krogius L; Saarela M; Korpela R; Palva A
    Am J Gastroenterol; 2005 Feb; 100(2):373-82. PubMed ID: 15667495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota.
    Jeffery IB; O'Toole PW; Öhman L; Claesson MJ; Deane J; Quigley EM; Simrén M
    Gut; 2012 Jul; 61(7):997-1006. PubMed ID: 22180058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome.
    Duboc H; Rainteau D; Rajca S; Humbert L; Farabos D; Maubert M; Grondin V; Jouet P; Bouhassira D; Seksik P; Sokol H; Coffin B; Sabaté JM
    Neurogastroenterol Motil; 2012 Jun; 24(6):513-20, e246-7. PubMed ID: 22356587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The putative role of the intestinal microbiota in the irritable bowel syndrome.
    Collins SM; Denou E; Verdu EF; Bercik P
    Dig Liver Dis; 2009 Dec; 41(12):850-3. PubMed ID: 19740713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects.
    Kassinen A; Krogius-Kurikka L; Mäkivuokko H; Rinttilä T; Paulin L; Corander J; Malinen E; Apajalahti J; Palva A
    Gastroenterology; 2007 Jul; 133(1):24-33. PubMed ID: 17631127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hypersensitivity to colonic distension of IBS patients can be transferred to rats through their fecal microbiota.
    Crouzet L; Gaultier E; Del'Homme C; Cartier C; Delmas E; Dapoigny M; Fioramonti J; Bernalier-Donadille A
    Neurogastroenterol Motil; 2013 Apr; 25(4):e272-82. PubMed ID: 23433203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction: An Evidence of Dysbiosis.
    Shukla R; Ghoshal U; Dhole TN; Ghoshal UC
    Dig Dis Sci; 2015 Oct; 60(10):2953-62. PubMed ID: 25784074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prebiotic effects: metabolic and health benefits.
    Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
    Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reassessment of the role of methane production between irritable bowel syndrome and functional constipation.
    Furnari M; Savarino E; Bruzzone L; Moscatelli A; Gemignani L; Giannini EG; Zentilin P; Dulbecco P; Savarino V
    J Gastrointestin Liver Dis; 2012 Jun; 21(2):157-63. PubMed ID: 22720304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of pathogenic microbes and commensal bacteria in irritable bowel syndrome.
    Collins S; Verdu E; Denou E; Bercik P
    Dig Dis; 2009; 27 Suppl 1():85-9. PubMed ID: 20203502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesalazine (5-aminosalicylic acid) alters faecal bacterial profiles, but not mucosal proteolytic activity in diarrhoea-predominant irritable bowel syndrome.
    Andrews CN; Griffiths TA; Kaufman J; Vergnolle N; Surette MG; Rioux KP
    Aliment Pharmacol Ther; 2011 Aug; 34(3):374-83. PubMed ID: 21671966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Microbiota and irritable bowel syndrome].
    Ducrotté P
    Gastroenterol Clin Biol; 2010 Sep; 34 Suppl 1():S52-6. PubMed ID: 20889005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options.
    Bonfrate L; Tack J; Grattagliano I; Cuomo R; Portincasa P
    Scand J Gastroenterol; 2013 Sep; 48(9):995-1009. PubMed ID: 23964766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More than constipation - bowel symptoms in Parkinson's disease and their connection to gut microbiota.
    Mertsalmi TH; Aho VTE; Pereira PAB; Paulin L; Pekkonen E; Auvinen P; Scheperjans F
    Eur J Neurol; 2017 Nov; 24(11):1375-1383. PubMed ID: 28891262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives.
    Salonen A; de Vos WM; Palva A
    Microbiology (Reading); 2010 Nov; 156(Pt 11):3205-3215. PubMed ID: 20705664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of probiotic bacteria on the intestinal microbiota in irritable bowel syndrome.
    Ng SC; Lam EF; Lam TT; Chan Y; Law W; Tse PC; Kamm MA; Sung JJ; Chan FK; Wu JC
    J Gastroenterol Hepatol; 2013 Oct; 28(10):1624-31. PubMed ID: 23800182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probiotics in the management of functional bowel disorders: promise fulfilled?
    Quigley EM
    Gastroenterol Clin North Am; 2012 Dec; 41(4):805-19. PubMed ID: 23101688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.